Epidemiological study design of asymptomatic infection of the 2019 novel coronavirus
COVID-19 is caused by the 2019 novel coronavirus (2019-nCoV). COVID-19 clinical cases are considered as the principal source of infection, however, asymptomatic cases may also play a role in the transmission. Significant gap exists in terms of the proportion or prevalence and transmissibility of asymptomatic cases. This study design plans to use data from areas with different epidemiological profiles to investigate the COVID-19 epidemic in China. In each selected region, both general community residents and key populations at high risk of COVID-19 infection, including recovered COVID-19 cases, close contacts of confirmed COVID-19 cases, medical professionals, investigators at CDCs, and visitors to fever clinics, will be recruited and examined for viral RNA of 2019-nCoV and serum antibodies. Prevalence and characterization of asymptomatic cases will be determined, stratified by varied demographics and exposure risk. During the follow-up, the change in the serum antibodies will be studied prospectively in the symptomatic and asymptomatic cases to address the scientific and public health concerns of infectivity and transmissibility of 2019-nCoV.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi - 41(2020), 10 vom: 10. Okt., Seite 1577-1581 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
He, N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2019 novel coronavirus |
|---|
| Anmerkungen: |
Date Completed 17.12.2020 Date Revised 17.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3760/cma.j.cn112338-20200723-00975 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313119074 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313119074 | ||
| 003 | DE-627 | ||
| 005 | 20231225145900.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3760/cma.j.cn112338-20200723-00975 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1043.xml |
| 035 | |a (DE-627)NLM313119074 | ||
| 035 | |a (NLM)32736419 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 1 | |a He, N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Epidemiological study design of asymptomatic infection of the 2019 novel coronavirus |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.12.2020 | ||
| 500 | |a Date Revised 17.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a COVID-19 is caused by the 2019 novel coronavirus (2019-nCoV). COVID-19 clinical cases are considered as the principal source of infection, however, asymptomatic cases may also play a role in the transmission. Significant gap exists in terms of the proportion or prevalence and transmissibility of asymptomatic cases. This study design plans to use data from areas with different epidemiological profiles to investigate the COVID-19 epidemic in China. In each selected region, both general community residents and key populations at high risk of COVID-19 infection, including recovered COVID-19 cases, close contacts of confirmed COVID-19 cases, medical professionals, investigators at CDCs, and visitors to fever clinics, will be recruited and examined for viral RNA of 2019-nCoV and serum antibodies. Prevalence and characterization of asymptomatic cases will be determined, stratified by varied demographics and exposure risk. During the follow-up, the change in the serum antibodies will be studied prospectively in the symptomatic and asymptomatic cases to address the scientific and public health concerns of infectivity and transmissibility of 2019-nCoV | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 2019 novel coronavirus | |
| 650 | 4 | |a Asymptomatic infection | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Sero-epidemiological study | |
| 700 | 1 | |a Lu, Y H |e verfasserin |4 aut | |
| 700 | 1 | |a Li, L M |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, H B |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, W Z |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Z J |e verfasserin |4 aut | |
| 700 | 0 | |a Collaboration Group for the Emergency Research Project of Novel Coronavirus Pneumonia for National Natural Science Foundation of China |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi |d 1993 |g 41(2020), 10 vom: 10. Okt., Seite 1577-1581 |w (DE-627)NLM012811793 |x 0254-6450 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2020 |g number:10 |g day:10 |g month:10 |g pages:1577-1581 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112338-20200723-00975 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2020 |e 10 |b 10 |c 10 |h 1577-1581 | ||